Teresa P.
- Country
- Spain
- Department
- Oncology
Research Overview
- Phase 3 Randomized Double-Blind Study of Tucidinostat and Nivolumab Versus Placebo and Nivolumab in Metastatic or Unresectable Melanoma
- Efficacy and Safety Evaluation of Enfortumab Vedotin and Pembrolizumab in Advanced Melanoma: A Phase II, Open-Label, Multicenter Study
- Evaluation of Neoadjuvant Cemiplimab and Imiquimod with Laser Therapy in High-Risk Resectable Cutaneous Basal Cell Carcinoma
Data & Insights
Has run more than one trial at 4 of 59 partner sites.
Specializations
Breast Cancer and Gynecologic Oncology
Clinical research activity includes a strong focus on breast cancer, spanning hormone receptor-positive and HER2-negative disease, HER2-positive disease, triple-negative breast cancer, and metastatic breast cancer. The portfolio also extends to endometrial cancer, ovarian cancer, and other gynecological tumors.
- Early and advanced breast cancer
- Metastatic and recurrent gynecologic malignancies
- Targeted and endocrine-based oncology
Work in this area reflects involvement in modern treatment strategies for breast and gynecologic cancers, with interest in disease control across early-stage, locally advanced, and metastatic settings.
Gastrointestinal and Hepatobiliary Oncology
Another major therapeutic domain is gastrointestinal cancer, including colorectal cancer, gastric cancer, gastroesophageal junction adenocarcinoma, pancreatic adenocarcinoma, hepatocellular carcinoma, and biliary tract cancer. The investigator is also connected with studies in advanced solid tumors arising in the digestive system.
- Colorectal and rectal cancer
- Pancreatic and gastric malignancies
- Liver and biliary tract cancers
This research landscape includes interest in difficult-to-treat digestive cancers and liver-directed oncologic care, with emphasis on therapeutic innovation in advanced disease.
Hematologic Malignancies
The investigator is active in blood cancers, with studies involving acute lymphoblastic leukemia, acute myeloid leukemia, chronic myeloid leukemia, chronic lymphocytic leukemia, lymphoma, multiple myeloma, and Waldenström macroglobulinemia. The portfolio also includes relapsed and refractory hematologic disease.
- Leukemia
- Lymphoma
- Multiple myeloma and related plasma cell disorders
These activities show engagement with therapeutic development across aggressive and chronic hematologic conditions, including treatment-resistant disease states.
Immune-Mediated, Inflammatory, and Transplant-Related Disorders
Clinical interests also cover autoimmune and inflammatory diseases, such as ulcerative colitis, Crohn’s disease, psoriasis, atopic dermatitis, hidradenitis suppurativa, and prurigo nodularis. Additional involvement is seen in kidney transplantation and antibody-mediated rejection.
- Inflammatory bowel disease
- Dermatologic immune-mediated disorders
- Transplant rejection and graft dysfunction
The research scope in this domain includes chronic immune dysregulation and post-transplant complications, linking therapeutic interest in inflammatory control and graft preservation.
Cardiometabolic, Neurologic, and Ophthalmic Diseases
The investigator’s portfolio further includes cardiovascular disease, atherosclerotic cardiovascular disease, stroke, hemophilia, liver disease, nephrology conditions such as IgA nephropathy and lupus nephritis, and eye disorders including age-related macular degeneration, diabetic macular edema, and glaucoma.
- Thrombotic and vascular disease
- Neurologic ischemic disorders
- Retinal and optic nerve disease
These areas indicate participation in studies addressing vascular risk, neurological injury, bleeding disorders, renal inflammation, and vision-threatening disease.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.